Structural Formula (Levetiracetam Injection Civica 1)
Levetiracetam Injection
Product Images NDC 72572-360
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Levetiracetam (NDC 72572-360). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Civica, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Layout 1 (Levetiracetam Injection Civica 10)
This text is a product label containing product information, such as the GTIN (Global Trade Item Number), SN (Serial Number), EXP (Expiration Date), and LOT (Lot Number). It is commonly found on the packaging of retail products to provide tracking and identification information.*
Figure 1: Responder Rate (≥50% Reduction From Baseline) In Study 1 (Levetiracetam Injection Civica 2)
Figure 2: Responder Rate (≥50% Reduction From Baseline) In Study 2: Period A (Levetiracetam Injection Civica 3)
Figure 3: Responder Rate (≥50% Reduction From Baseline) In Study 3 (Levetiracetam Injection Civica 4)
This is a chart showing the percentage of patients in a clinical trial who were given placebo or Levetiacetam 3000 mg/cey (=130) and how many patients were in each group. There is no additional information available.*
Figure 4: Responder Rate (≥ 50% Reduction From Baseline) In Study 4 (Levetiracetam Injection Civica 5)
This appears to be a chart or table representing percentages for placebo and levetiracetam in relation to an unknown variable. The numbers "4%" and "196%" are displayed, as well as a comparison between placebo (N=7) and levetiracetam (N=101) groups. It is not clear what the chart is specifically addressing or measuring.*
Figure 5: Responder Rate For All Patients Ages 1 Month To < 4 Years (≥ 50% Reduction From Baseline) In Study 5 (Levetiracetam Injection Civica 6)
Figure 6: Responder Rate (≥50% Reduction From Baseline) In Pgtc Seizure Frequency Per Week In Study 7 (Levetiracetam Injection Civica 7)
Plb568 (Levetiracetam Injection Civica 8)
This is a description of a medication with the NDC code 72572:36001 R used for injection. The medication is Levetiracetam and the dosage instructions are available on the package insert. The medication should be stored at a temperature between 25°C and 190°C. The medication is indicated for Intravenous Use ONLY and is packaged in a 5mL Single Dose Vial (Portugal) SA.*
Plb569 (Levetiracetam Injection Civica 9)
This is a description of a medication called PLB569-CIV/1, which is a vial containing 500mg of levetiracetam along with 8.2mg of sodium acetate tihydrate and 45mg of sodium chloride. The solution also contains glacial acetic acid for pH adjustment to 6. The medication is intended for intravenous use only and must be diluted prior to administration. There are 25 units of the medication, in 5mL single dose vials that need to be stored in a carton at room temperature, with excursions permitted between 15°C to 30°C (59°F to 86°F). The manufacturer is Hikma Farmacéutica (Portugal), SA and the distributor is Civica, Inc from Lehi, Utah 84043.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
